60 results
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
HIPAA, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679), and other similar state privacy laws (collectively, the “Privacy Laws … Security Council, the European Union, His Majesty’s Treasury-UK, or other relevant sanctions authority (collectively, “Sanctions”) and the Company
424B5
cqcl8r qz6c
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
teys9
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-1.1
whif7u i8t
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
3j9 w6496
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-10.1
0j7x53aw30zpr ai
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
a0pdbg9hdeiu
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K/A
EX-99.2
yvkwdislcnahf65ulxsl
26 Jun 20
Other Events
5:08pm
8-K
EX-99.1
aewncir
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.1
4tpll 9ddmlulr
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
mycw12j6jm
29 Apr 20
Proxy related to merger
3:20pm